Grand Parkway Pediatrics — Sugar Land, Texas

Grand Parkway Pediatrics is a clinical research site located in Sugar Land, Texas, United States 77479.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Grand Parkway Pediatrics has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis.

Sponsors: MEDA Pharma GmbH & Co. KG.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sugar Land

Browse all research sites in Texas · View every site in Sugar Land

• Memorial Hermann Surgical Hospital First Colony
• Memorial Hermann Sugar Land Hospital
• The University of Texas, MD Anderson Cancer Center - Sugar Land
• Houston Methodist Hospital - Sugarland
• Houston Methodist Sugar Land Hospital
• Houston Methodist Hospital Sugar Land
• 8401176 - Methodist Sugar Land Hospital
• Memorial Hermann Community Hospitals
• MD Anderson in Sugar Land
• Novo Nordisk Investigational Site
• Texas Oncology Cancer Center Sugar Land
• Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Grand Parkway Pediatrics?

Grand Parkway Pediatrics has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Grand Parkway Pediatrics conducted?

Grand Parkway Pediatrics has 1 clinical trials on record. Their work covers Atopic Dermatitis.

Is Grand Parkway Pediatrics accredited by Crixeo Clinical Trials?

Grand Parkway Pediatrics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Grand Parkway Pediatrics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.